Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure

Muendlein, A; Heinzle, C; Leiherer, A; Brandtner, EM; Geiger, K; Gaenger, S; Fraunberger, P; Mader, A; Saely, CH; Drexel, H

Muendlein, A (通讯作者),Voralberg Inst Vasc Invest & Treatment VIVIT, Carinagasse 47, A-6800 Feldkirch, Austria.

CLINICAL BIOCHEMISTRY, 2023; 121 ():

Abstract

Background: Heart failure confers a high burden of morbidity and mortality. However, risk prediction in heart failure patients still is limited. Blood......

Full Text Link